Treatment of drug-resistant TB with new and repurposed medications: A supplemental field guide for nurses

The guide focuses on issues of importance to nurses and the types of care they provide to individuals with drug-resistant TB.

Read More →

TB Alliance launches “Nix-TB” clinical trial to test new XDR-TB treatment

First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB.

Read More →

Report: Securing new drugs for future generations: The pipeline of antibiotics

The report provides a high-level assessment of the development pipeline for new antibiotics, and sets out the Review’s initial proposals for the action needed at a global level to kick-start antibiotic drug discovery efforts.

Read More →

Open letter to WHO: Recording and reporting of preventive TB therapy in children

Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.

Read More →

Letter from TB community re: intellectual property rights to sutezolid

The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.

Read More →

WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers

New WHO Model List of Essential Medicines published; After about 45 years of scarce innovation for TB medicines, 5 new products are included in the List. Four of these, including bedaquiline and delamanid, target multidrug-resistant TB.

Read More →

TB CAB, TAG open letter to the Global Plan Development Task Force

Re: Programmatic and research targets for the Global Plan to Stop TB, 2016–2020

Read More →

Global tuberculosis control: Toward the 2015 targets and beyond

Beyond 2015, global action should be based on strategies that exploit technical and operational innovations to improve TB control and promote universal health coverage and social protection mechanisms as a means to ensure access to quality care while avoiding catastrophic costs incurred by patients.

Read More →

Tuberculosis in the African continent: A comprehensive review

To achieve maximum TB care and control, countries must strengthen their public health infrastructure and move towards universal access to prevention, diagnostic and treatment services for all forms of TB with accelerated research in TB control.

Read More →

The End TB Strategy: India can blaze the trail

How is the ‘End TB Strategy’ relevant in the Indian context, and how can India be a world leader in implementing the End TB Strategy?

Read More →

Page 1 of 56 · Total posts: 10

1 2 Last→